Clinical Trial Update: Trial of Curcumin in Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating curcumin in advanced pancreatic cancer has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Neoplasms

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreatic Neoplasms, Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-08-28